World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
123
Citations
75803
World Ranking
3287
National Ranking
43

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Joan Bladé is affiliated with the University of Barcelona in Spain. Their research primarily focuses on medicine, with a strong emphasis on hematology and molecular biology. They have contributed extensively to the fields of oncology, genetics, and immunology.

The scientist's major research topics include:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Peptidase Inhibition and Analysis
  • Cancer Treatment and Pharmacology
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Bladé's recent publications highlight their focus on multiple myeloma and related hematologic diseases. Notable papers include:

  • "Extramedullary disease in multiple myeloma: a systematic literature review," 2022, Blood Cancer Journal
  • "Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma," 2023, New England Journal of Medicine
  • "Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group," 2021, The Lancet Oncology
  • "Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial," 2020, The Lancet Haematology
  • "Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations," 2021, British Journal of Haematology

Frequent co-authors collaborating with Joan Bladé include:

  • Laura Rosiñol
  • María-Victoria Mateos
  • Jesús F. San Miguel
  • Albert Oriol
  • Joaquin Martínez-López

Key publication venues where Bladé's work appears often are:

  • Clinical Lymphoma Myeloma & Leukemia
  • Blood
  • Blood Cancer Journal
  • Journal of Clinical Oncology
  • British Journal of Haematology

The volume of publications in these venues demonstrates a consistent research output particularly in hematology and oncology topics related to multiple myeloma and blood cancers.

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

    Joan BladÉ;Diana Samson;Donna Reece;Jane Apperley

  • Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    S. Vincent Rajkumar;Jean Luc Harousseau;Brian Durie;Kenneth C. Anderson

  • Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    Jesús F. San-Miguel;Vânia T.M. Hungria;Sung Soo Yoon;Meral Beksac

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

    Sagar Lonial;Brendan M Weiss;Saad Z Usmani;Seema Singhal

  • Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    Pieter Sonneveld;Hervé Avet-Loiseau;Sagar Lonial;Saad Usmani

  • Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

    Antonio Palumbo;Roman Hajek;Michel Delforge;Martin Kropff

  • Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

    Robert Z. Orlowski;Arnon Nagler;Pieter Sonneveld;Joan Bladé

  • Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    J Flores-Montero;L Sanoja-Flores;B Paiva;N Puig

  • Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.

    Paul Gerard Richardson;Pieter Sonneveld;Michael Schuster;David Irwin

  • Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

    María-Victoria Mateos;Miguel-Teodoro Hernández;Pilar Giraldo;Javier de la Rubia

  • Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

    María-Victoria Mateos;Albert Oriol;Joaquín Martínez-López;Norma Gutiérrez

Frequent Co-Authors

Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Juan José Lahuerta
Juan José Lahuerta Complutense University of Madrid
Jesús F. San Miguel
Jesús F. San Miguel University of Navarra
Albert Oriol
Albert Oriol Autonomous University of Barcelona
Ramón García-Sanz
Ramón García-Sanz University of Salamanca
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Emili Montserrat
Emili Montserrat University of Barcelona
Michele Cavo
Michele Cavo University of Bologna
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Alberto Orfao
Alberto Orfao University of Salamanca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine and healthcare, a range of fast track medical and nursing programs are available online. These streamlined pathways can help you launch or advance your medical career quickly, especially if you are looking to become a registered nurse or pursue more advanced practice roles.

If you are considering doctoral-level nursing, you may want to explore short dnp programs. These programs are designed for working professionals who need flexibility and a quicker route to completing their degree. In addition, many prospective students seek out the easiest dnp program reddit recommendations to find options that best fit their learning style and life circumstances.

For those interested in mental health care, there are also psych np programs available online, allowing you to specialize and meet the rising demand for mental health professionals. Online degrees in these areas can open doors to a variety of clinical and leadership roles, supporting your goals in the rapidly evolving healthcare sector.

Best Scientists Citing Joan Bladé

Trending Scientists

Recently Published Articles